LNP Surface Charge and V-ATPase in Nucleic Acid Delivery

Efficient nucleic acid delivery is often discussed as a problem of nanoparticle design: researchers adjust lipid composition, ionizable-lipid chemistry, particle size, or surface charge to influence uptake and biodistribution. The study Surface charge of LNP and V-ATPase activity of target cell synergize in functional delivery of nucleic acid in vitro and in vivo proposes a broader model. The authors argue that LNP tropism and functional delivery emerge from an interaction between the particle’s surface charge and the endo/lysosomal state of the target cell. The central evidence is reported in the reference study by Yang and colleagues.

Study Background and Research Question

Early cationic lipid systems were designed to bind negatively charged nucleic acids and promote interaction with cell membranes. Although this principle supported cellular uptake, strongly cationic formulations can also increase toxicity and immune activation. Ionizable and near-neutral LNPs subsequently became important alternatives, particularly for systemic delivery, but neutral particles commonly show substantial liver accumulation. Formulations containing permanently cationic or anionic lipids can redirect distribution toward other tissues, including the lung or spleen, yet the biological basis of these patterns is not fully explained.

The reference study focuses on a less examined variable: the functional state of the recipient cell’s endosomal and lysosomal machinery. These compartments regulate nanoparticle trafficking, acidification, cargo release, degradation, and eventual access of nucleic acid to the cytosol. V-ATPase, the vacuolar proton pump that contributes to organelle acidification, therefore represents a plausible determinant of whether internalized LNPs produce functional delivery. The research question was whether V-ATPase activity interacts with LNP surface charge to control delivery in cultured cells and in animals.

Key Innovation from the Reference Study

The study’s main innovation is a target-aware model of LNP delivery. Instead of assuming that one surface charge has an intrinsically superior performance, the authors compare charge states against different cellular environments and perturbations. Their results indicate that neutral LNPs perform better when target cells have relatively favorable V-ATPase activity, whereas positively charged LNPs can perform better in a condition associated with reduced V-ATPase activity. This reframes tropism as a property of the particle–cell pair rather than of the LNP alone.

This concept also connects cell culture observations with organ-level behavior. In the animal experiments, neutral and positively charged LNPs showed different distribution preferences, with neutral formulations associated with liver delivery and positively charged formulations associated with lung delivery. The authors interpret these patterns through the same charge–V-ATPase framework, while also examining how the reticuloendothelial system and adsorbed protein corona may modify the outcome.

Methods and Experimental Design Insights

The experimental design is valuable because it combines comparative formulation analysis with manipulation of the target-cell environment. In vitro experiments used cells maintained in serum-containing or serum-free conditions, described as Fed and -FBS cells, respectively. These conditions were used to create different cellular states and to compare the functional performance of neutral and positively charged LNPs. The study also included negatively charged LNPs in experiments addressing the relationship between V-ATPase activity and delivery.

Mechanistic support came from two complementary perturbation strategies. Pharmacological inhibition of V-ATPase activity was used to test whether reducing proton-pump function impaired delivery by neutral LNPs. A genetic intervention involving ATP6-V1H was used in the authors’ system to examine whether increased V-ATPase activity enhanced delivery mediated by negatively charged LNPs. Together, these experiments move the work beyond a correlation between serum condition and transfection: they directly test whether endo/lysosomal function is relevant to the delivery phenotype.

In vivo studies compared organ-level delivery after administration of LNPs with different surface charges. The authors also preconditioned the reticuloendothelial system with empty LNPs to determine whether this altered subsequent functional delivery. Finally, they characterized major protein-corona components associated with neutral and positively charged LNPs recovered in vivo. This combination of functional delivery, organ distribution, cellular perturbation, RES conditioning, and corona analysis provides a multidimensional view of LNP behavior.

Protocol Parameters

• LNP charge comparison: Compare neutral, positively charged, and negatively charged formulations while keeping the nucleic acid payload and functional readout consistent where possible. The charge-dependent comparisons are literature-backed by the reference study; applying them to a new formulation is a workflow recommendation.
• Cell-state condition: Include serum-containing and serum-free conditions as defined experimental variables, but interpret them as models of altered cell state rather than direct substitutes for physiological tissues.
• V-ATPase perturbation: Use pharmacological inhibition or ATP6-V1H-directed genetic manipulation with appropriate untreated and vehicle or transfection controls. The study supports these perturbations as mechanistic tests, not as universal delivery enhancers.
• In vivo distribution: Evaluate liver and lung delivery separately when comparing neutral and positively charged LNPs, and distinguish particle accumulation from functional nucleic acid expression.
• RES preconditioning and corona analysis: Empty-LNP preconditioning can be used to probe RES involvement, while protein-corona profiling should be interpreted as compositional evidence unless individual corona components are tested causally.

Core Findings and Why They Matter

In cultured cells, neutral LNPs produced more efficient functional transfection in Fed cells than in -FBS cells. In contrast, positively charged LNPs performed better in -FBS cells than in Fed cells. The authors associate these opposing responses with differences in V-ATPase activity, suggesting that serum-dependent changes in cell physiology can reverse the apparent ranking of LNP formulations. This is important for mRNA delivery and transfection studies because an LNP that appears optimal under one culture condition may not remain optimal after changes in serum exposure, nutrient state, or cell model.

The perturbation experiments reinforce this interpretation. Inhibiting V-ATPase activity reduced delivery by neutral LNPs in vitro and in vivo. The authors further report that ATP6-V1H knockdown enhanced delivery by negatively charged LNPs in their experimental system, which they associate with elevated V-ATPase activity. These results support a model in which endosomal acidification or related V-ATPase-dependent processing is not merely a downstream event after uptake; it can help determine whether a particle’s surface charge is compatible with productive intracellular trafficking.

The in vivo findings extend the model from cell culture to organ tropism. Neutral LNPs preferentially supported liver delivery, whereas positively charged LNPs showed stronger lung delivery. Preconditioning the RES with empty LNPs enhanced functional lung delivery by positively charged LNPs but did not produce the same enhancement for liver delivery. Thus, organ targeting was influenced not only by charge but also by the prior state of systemic clearance and immune-associated nanoparticle handling.

Protein-corona analysis added another layer of interpretation. Neutral and positively charged LNPs shared many major corona components, but positively charged particles contained higher levels of coagulation factors and hemoglobins. This observation does not by itself establish that these proteins cause lung tropism. It does, however, show why nominal surface charge should not be treated as the only relevant property after administration: serum proteins can reshape the biological identity presented to cells and tissues.

Comparison with Existing Internal Articles

The internal article on dual-mode reporter mRNA delivery emphasizes transcript-level features such as capping, nucleotide modification, fluorescence tracking, and reporter expression. That perspective is complementary to the reference study. The LNP paper concentrates on the carrier–target interface and shows that delivery performance depends on cell physiology, while the internal article focuses on how a reporter transcript can make uptake and expression easier to observe.

A second internal workflow discussion on optimizing delivery and imaging experiments is relevant to assay planning, particularly when fluorescence and luminescence are used together. The reference study adds an important interpretive caution: a weak reporter signal may reflect charge–cell-state incompatibility or altered intracellular processing, not simply poor uptake or low translation efficiency. These articles should therefore be read as workflow complements rather than as independent validation of the specific mechanistic model.

Limitations and Transferability

The findings are mechanistically suggestive but should not be generalized without qualification. Fed versus -FBS culture is a controlled perturbation, not a complete representation of tissue nutrient status, serum exposure, or disease-associated endo/lysosomal remodeling. Likewise, pharmacological V-ATPase inhibition may affect more than the intended delivery pathway, and genetic manipulation of ATP6-V1H can alter broader aspects of cell physiology. Appropriate controls are essential before assigning a change in reporter output specifically to endosomal acidification.

The organ-level results also distinguish distribution from mechanism. Liver and lung tropism were associated with charge classes, but the study does not imply that charge alone determines tissue specificity. Protein corona composition, RES processing, cell-type abundance, vascular interactions, and intracellular trafficking may all contribute. The corona findings are especially useful for hypothesis generation, but shared abundance of a protein does not prove that it mediates delivery.

Transfer to a particular mRNA, lipid composition, dose, route, or disease model therefore requires empirical validation. A useful experimental extension is to pair particle tracking with a functional reporter and to record cell-state variables alongside transfection output. This can help separate uptake, intracellular localization, endosomal processing, and protein production instead of collapsing them into a single measurement.

Why this cross-domain matters, maturity, and limitations

Applying this framework to modified reporter mRNA is scientifically reasonable because the reference study addresses functional nucleic acid delivery, while reporter mRNA provides separate signals for cargo presence and biological expression. However, the paper does not directly validate every Cap1-capped or chemically modified transcript, and it does not establish that a particular reporter architecture will overcome an unfavorable LNP–cell interaction. The cross-domain implication is therefore hypothesis-generating: transcript chemistry and dual readouts can improve measurement, but they do not replace characterization of LNP charge, target-cell V-ATPase state, RES effects, and intracellular fate.

Research Support Resources

For similar delivery-tracking and reporter-expression workflows, researchers can use EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) (SKU R1010). This 5-moUTP modified mRNA combines a Cap1 structure, Cy5 labeling, and Firefly Luciferase expression, supporting direct fluorescence-based cargo tracking alongside luminescent functional readout. It may be useful for testing innate immune activation suppression, mRNA delivery and transfection, translation efficiency assays, and in vivo bioluminescence imaging, provided that the LNP formulation and target-cell conditions are optimized independently.